Profitelligence Profitelligence · Filing Ledger Open WST research →

Form 8-K · Current Report · Filed 2026-05-11

West Pharmaceutical Services Discloses Material Cybersecurity Incident

On May 7, 2026, West Pharmaceutical Services, Inc.

Filer
West Pharmaceutical Services Inc. WST · NYSE
Filed
Accession
0000105770-26-000068
CIK
0000105770
Signal
High impactHealthcare

Details

disclosed a material cybersecurity incident where certain data was exfiltrated and systems were encrypted. The company detected the intrusion on May 4, 2026, and activated its incident response protocols, including taking systems offline globally, notifying law enforcement, and engaging external cyber-forensic experts. The incident has temporarily disrupted business operations globally, although some critical processes have restarted. The financial impact is yet to be determined. West is leveraging its business continuity plans and working with customers to mitigate risk and minimize delays.

Items reported

Item events

Reported Item

Material Agreement Amendment Regulatory Investigation Major Legal Settlement

Market reaction

Close before filing

$325.92

Next session

-4.2%

Since filing

+4.6%

Latest close

$340.96

What happened, not what will happen — closing prices around the filing date.

Precedent

Previous filings from WST reporting the same item, with the next session's move:

Insider tape

Within 45 days of this filing, WST insiders reported 16 Form 4 transactions — net selling of $68K.

Full WST insider history →

About West Pharmaceutical Services Inc.

West Pharmaceutical Services Inc. is a leading global provider of innovative solutions for injectable drug administration. The company specializes in designing and manufacturing packaging and delivery systems specifically for pharmaceuticals, biologics, and vaccines. West Pharmaceutical Services plays a crucial role in ensuring the safety and efficiency of drug delivery through its products, which include stoppers, seals, containers, and pre-fillable syringe systems. Catering to a diverse range of healthcare and pharmaceutical clients, the company's offerings are integral in the development and distribution of injectable therapies across various therapeutic categories, including oncology, diabetes, and infectious diseases. As a partner to some of the world's leading pharmaceutical companies, West Pharmaceutical Services contributes significantly to advancements in medical treatments and healthcare technologies globally. Its commitment to quality and innovation underscores its importance in the pharmaceutical supply chain and enhances drug efficacy, ultimately impacting patient care and treatment outcomes.

Exchange NYSE Industry Medical Instruments & Supplies Company website ↗

Never miss another WST filing

Profitelligence watches EDGAR around the clock and alerts you within seconds.

Set up free alerts